-
Kenya's economy faces climate change risks: World Bank
-
Southeast Asia's largest dinosaur identified in Thailand
-
Drones to fight school shooters? One US company says yes
-
Zimbabwe tobacco hits new highs under smallholder contracts
-
India hikes fuel prices as Middle East war strains supplies
-
Markets wait on Trump-Xi summit, Seoul hits record
-
Canada's Cohere embraces 'low drama' amid AI giant tumult
-
Egypt farmers hit by Iran war price surge
-
LVMH sells Marc Jacobs to WHP Global, which will form partnership with G-III
-
CIA director visits Cuba as island runs out of oil
-
Closing arguments in blockbuster trial pitting Musk against OpenAI
-
Romanian metal, Aussie star through to Eurovision final
-
Eurovision second semi starts with a 'Bangaranga'
-
US tariffs, cyberattack drive Jaguar Land Rover into loss
-
Austrian feminist artist Valie Export dies aged 85
-
IMF sees risks to global growth forecast over sustained Iran war
-
China's Weichai wins battle for Ferretti yacht maker
-
Princess Catherine wraps up Italy visit with pasta class
-
Honda suspends plans for new electric vehicle plant in Canada
-
Sniffer dogs police Cannes' cocaine-fuelled party scene
-
Spain gears up for August total solar eclipse
-
Tech stocks rally rolls on as US-China talks underway
-
Stocks diverge tracking tech, US-China talks
-
Stars flying into Cannes in private jets 'obscene', say ex-pilots
-
UK economy resilient as Mideast war, political risks loom
-
U2 surprise fans in Mexico City to shoot music video
-
Asia stocks uneven as investors assess high-stakes Trump-Xi talks, AI rally
-
Burberry returns to full-year profit on turnaround plan
-
Denmark, Australia in the spotlight in Eurovision second semi
-
Xi warns Trump on Taiwan at Beijing summit
-
Bone appetit: Paris pups lap up treats at dog-centric spots
-
India bars sugar exports until September
-
Honda posts operating loss, first since 1957
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
Historic Swiss solar-powered plane crashes into sea
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
S&P 500, Nasdaq end at records as oil prices retreat
-
Warsh confirmed as Fed chair as central bank faces Trump assault
-
From Black Death to Covid, ships have long hosted outbreaks
-
Stocks rise ahead of US-China summit
-
US wholesale prices jump 6.0% year-on-year in April, highest since 2022
-
Italy cheers UK's Catherine on first foreign visit since cancer diagnosis
-
Eurovision stage inspired by Viennese opera
-
Stocks waver, oil steady ahead of US-China summit as Iran talks stall
-
War in Middle East: latest developments
-
After the hobbits, director Peter Jackson tackles 'Tintin'
-
Real Madrid win legal battle over Bernabeu concert noise
Adding peanuts to young children's diet can help avoid allergy: study
Including peanuts in children's diets early in life could help stave off allergies against the legume, which can be fatal and affect swathes of youngsters globally, according to a new study Friday.
Researchers found that introducing peanut products to babies and infants, and gradually increasing exposure, led to greater tolerance for the common allergen.
The peer-reviewed study, published in The Lancet, involved 146 peanut-allergic children aged between zero and three over two-and-a-half years.
Of the group, 96 were given peanut protein powder every day, with the dose increasing progressively to the equivalent of six peanuts. The other children received a placebo of oat flour.
Twenty of the children who received peanut powder showed allergy remission, meaning no allergic reaction occurred six months after the therapy ended.
One child in the placebo group showed remission.
Six months after the treatment, the children in remission could tolerate a dose equivalent to 16 peanuts.
An additional 20 children who received peanut powder were considered 'desensitised', meaning they had a higher allergic threshold but were not considered in remission.
These children could tolerate a dose equivalent to between six and 12 peanuts six months after the treatment ended.
The youngest children in the study experienced remission the most often, and the best results were in those under 12 months.
"Very early interventions may provide the best opportunity to achieve remission", said co-author Stacie Jones.
- 'Considerable burden' -
Peanut allergies affect two percent of children in Western countries, according to the study, and can last a lifetime.
Affected children must avoid eating peanuts and have self-injectable adrenaline available to fight allergic shocks, which can be fatal if they are accidentally exposed.
Exposure can even occur when a child hugs someone who has just consumed peanuts.
"There are no treatment options, resulting in a considerable burden on allergic children and their caregivers to avoid accidental exposure," said co-author Wesley Burks.
"In severe cases, this can restrict peanut-allergic children's freedoms, particularly when it comes to navigating daycare or schools and public spaces where access to a safe diet is in jeopardy," he added.
Previous studies have produced similar results but the length of the latest studies makes it unique.
Although it provided important results, it may not reflect the behaviour of the children's bodies in real-world conditions.
The study was conducted under close medical supervision, and adrenaline injections were administered on 21 children during the trial.
L.Peeters--CPN